Business
Notice of Accession of Guarantor
Notice of Accession of Guarantor.
About this update from Hikma Pharmaceuticals Plc
[{"type":"text","content":"\n \nRNS Number : 8134L Hikma Pharmaceuticals Plc 10 September 2019 \n\n10 September 2019\n \n \nNOTICE OF ACCESSION OF GUARANTOR\nHikma Pharmaceuticals Public Limited Company(the \"Issuer\")\n \nNotice to the holders of the outstanding\nU.S.$500,000,000 4.25 per cent. Guaranteed Notes due 2020 (ISIN: XS1213834978)\n(the \"Notes\")\n \nThe Issuer refers to (i) the terms and conditions of the Notes (the \"Conditions\") set out in the prospectus dated 8 April 2015 relating to the Notes and (ii) a deed of guarantee dated 10 April 2015 between the Issuer and Arab Pharmaceutical Manufacturing PSC, Eurohealth (USA), Inc., Hikma Farmacêutica (Portugal) S.A., Hikma Pharmaceuticals LLC and West-Ward Pharmaceutical Corp. (together, the \"Original Guarantors\") in favour of the Holders and the Relevant Account Holders (each as defined therein) as modified by the accession letters executed on 29 April 2016 by (i) Roxane Laboratories Inc.; and (ii) West-Ward Columbus Inc.; and the accession letter executed on 21 August 2017 by Hikma Pharmaceuticals International Limited (formerly known as West-Ward Pharmaceuticals International Limited) (as further amended and supplemented from time to time) (the \"Deed of Guarantee\").\nCapitalised terms used in this Notice and not defined herein shall have the meanings set out in the Conditions and the Deed of Guarantee.\nNOTICE IS HEREBY GIVEN that, pursuant to and in compliance with the provisions of Condition 5.7 (Guarantor Group) and the Deed of Guarantee, as of 5 September 2019, the entity listed in the Schedule to this Notice (who is an indirect wholly-owned subsidiary of the Issuer) has, pursuant to an accession deed of guarantee dated 5 September 2019 (the \"Accession Deed of Guarantee\") and an accession deed of covenant dated 5 September 2019, become a Guarantor and agreed to:\n(i) perform and observe all the obligations expressed to be undertaken by a Guarantor under the Conditions, the Deed of Guarantee, a deed of covenant between the Issuer and the Original Guarantors dated 10 April 2015 as modified by the accession letters executed on 29 April 2016 by (i) Roxane Laboratories Inc.; and (ii) West-Ward Columbus Inc.; and the accession letter executed on 21 August 2017 by Hikma Pharmaceu...